Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 2/20 | 0.41 |
| ▸ | HCAR3 | P49019 | 5/20 | 0.41 |
| ▸ | STAT3 | P40763 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | THRA | P10827 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | CASP6 | P55212 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12021785 | 0.89 | HCAR3 (0.44) | ALDH1A1MAPTPTGS2BACE1HCAR3 | |
| SCHEMBL3091095 | 0.84 | HCAR3 (0.58) | ALDH1A1MAPTPTGS2HCAR3LMNA | |
| SCHEMBL192101 | 0.84 | HCAR3 (0.58) | ALDH1A1MAPTPTGS2HCAR3LMNA | |
| SCHEMBL191304 | 0.81 | VCAM1 (0.53) | ALDH1A1MAPTPTGS2BACE1RAB9A | |
| SCHEMBL544067 | 0.81 | ALDH1A1 (0.48) | ALDH1A1MAPTPTGS2BACE1HCAR3 | |
| SCHEMBL191305 | 0.81 | VCAM1 (0.53) | ALDH1A1MAPTPTGS2BACE1RAB9A | |
| SCHEMBL544066 | 0.81 | ALDH1A1 (0.48) | ALDH1A1MAPTPTGS2BACE1HCAR3 | |
| SCHEMBL7411665 | 0.75 | PTGS2 (0.47) | ALDH1A1MAPTPTGS2BACE1HCAR3 | |
| SCHEMBL7411663 | 0.75 | PTGS2 (0.47) | ALDH1A1MAPTPTGS2BACE1HCAR3 | |
| SCHEMBL10079161 | 0.75 | TSHR (0.66) | ALDH1A1MAPTRAB9ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110688-B2 | Method for producing indole derivative having piperidine ring | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| EP-1880995-B1 | METHOD FOR PRODUCING INDOLE DERIVATIVE HAVING PIPERIDINE RING | EISAI R&D MAN CO LTD (JP) | 2011-12-21 | — | — | EP | disclosed |
| US-20100197926-A1 | METHOD FOR PRODUCING INDOLE DERIVATIVE HAVING PIPERIDINE RING | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2010-08-05 | — | — | US | disclosed |
| EP-1880995-A1 | METHOD FOR PRODUCING INDOLE DERIVATIVE HAVING PIPERIDINE RING | Eisai R&D Management Co., Ltd. (JP) | 2008-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197926-A1 | METHOD FOR PRODUCING INDOLE DERIVATIVE HAVING PIPERIDINE RING | IDO2, IDO1, TPH2 | ALDH1A1 25/4885MAPT 2926/4885PTGS2 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.